Clinical Trials Sponsored by TCI Co., Ltd.

Total 10397 results

Cellid Co., Ltd.

Not yet recruiting

Immunogenicity and Safety of AdCLD-CoV19-1 OMI as a Booster: A COVID-19 Preventive Vaccine in Healthy Volunteers (COVID-19)

COVID-19 | Vaccines

Korea, Republic of
RemeGen Co., Ltd.

Recruiting

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Solid Tumor

China
RemeGen Co., Ltd.

Recruiting

Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema

Diabetic Macular Edema

China
RemeGen Co., Ltd.

Recruiting

RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC

NSCLC

China
Benobio Co., Ltd.

Not yet recruiting

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

Australia
RemeGen Co., Ltd.

Recruiting

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Advanced Solid Tumours

China
RemeGen Co., Ltd.

Not yet recruiting

A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation

Non-small Cell Lung Cancer

China
RemeGen Co., Ltd.

Recruiting

Study of Telitacicept in Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized

China
InventisBio Co., Ltd

Recruiting

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

Gout

United States
RemeGen Co., Ltd.

Recruiting

A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

Digestive Cancer

China
ATGC Co., Ltd.

Recruiting

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Glabellar Frown Lines

Korea, Republic of
Cellbion Co., Ltd.

Recruiting

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy

Prostate Cancer | mCRPC

Korea, Republic of
ILAb Co., Ltd.

Recruiting

MAD Study of IA-14069

Healthy | Rheumatoid Arthritis

United States
AriBio Co., Ltd.

Recruiting

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

Alzheimer Disease

Korea, Republic of, United States, United Kingdom
LitePharmTech Co., Ltd.

Recruiting

Study of Atropine Therapeutic Effect on Myopic Progression (STAMP)

Children | Myopia

Korea, Republic of
InventisBio Co., Ltd

Recruiting

Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients

Hyperuricemia

China
RemeGen Co., Ltd.

Recruiting

A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)

Systemic Lupus Erythematosus

United States, Colombia, Bulgaria, Poland, Puerto Rico, Argentina, Australia, Chile, Hungary, Spain, Germany, Philippines
RemeGen Co., Ltd.

Recruiting

A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Muscle Invasive Bladder Carcinoma

China
Medipost Co Ltd.

Recruiting

Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Korea, Republic of
Pharmasaga Co. Ltd.

Recruiting

Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects

Type II Diabetes

Taiwan
REDNVIA Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

Calcific Aortic Valve Disease

United States
RemeGen Co., Ltd.

Recruiting

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

Advanced Melanoma | Melanoma, Stage II | HER2-positive

China
PegBio Co., Ltd.

Recruiting

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China, Taiwan, Hong Kong
Microbio Co Ltd

Not yet recruiting

Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque Psoriasis

Plaque Psoriasis
Microbio Co Ltd

Recruiting

Safety and Potential Efficacy of MS-20 In Combination With Pembrolizumab for the Treatment of NSCLC

NSCLC Stage IV

Taiwan
NKMAX Co., Ltd.

Recruiting

A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment (SNK_ASTER)

Non-small Cell Lung Cancer

Korea, Republic of
Biosolution Co., Ltd.

Recruiting

Phase 2 Clinical Trial of CartiLife® in the United States

Articular Cartilage Defect | Articular Cartilage Degeneration

United States
RemeGen Co., Ltd.

Recruiting

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Solid Tumor

China
Anterogen Co., Ltd.

Recruiting

Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula

Crohn's Fistula

Korea, Republic of
Pharmicell Co., Ltd.

Recruiting

Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously (Cellgram-ED)

Erectile Dysfunction

Korea, Republic of
RemeGen Co., Ltd.

Recruiting

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Breast Cancer

China
Medipost Co Ltd.

Recruiting

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

Knee Osteoarthritis

Korea, Republic of
Anterogen Co., Ltd.

Recruiting

A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease

Crohn's Disease

Korea, Republic of
Biopeutics Co., Ltd

Not yet recruiting

ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure

Heart Failure

Austria
PegBio Co., Ltd.

Enrolling by invitation

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects

Obesity

China
Genoss Co., Ltd.

Completed

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis

Coronary Artery Disease
Maruho Co., Ltd.

Active, not recruiting

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

Systemic Sclerosis

Japan
PegBio Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

Obesity

China
Pharmicell Co., Ltd.

Active, not recruiting

To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.

Acute Myocardial Infarction

Korea, Republic of
InventisBio Co., Ltd

Completed

D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

NSCLC | Solid Tumor | EGFR T790M

China
Pharmicell Co., Ltd.

Completed

Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease

Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3B

Korea, Republic of
InventisBio Co., Ltd

Active, not recruiting

Study to Evaluate D-1553 in Subjects With Lung Cancer

NSCLC

China
RemeGen Co., Ltd.

Active, not recruiting

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

Biliary Tract Cancer

China
HysensBio Co., Ltd

Completed

Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients

Dentin Sensitivity

Korea, Republic of
RemeGen Co., Ltd.

Active, not recruiting

Evaluation of RC28-E Injection in Diabetic Retinopathy

Diabetic Retinopathy

China
RemeGen Co., Ltd.

Completed

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.

Moderate and Severe RheumatoId Arthritis

China
Menicon Co., Ltd.

Active, not recruiting

Clinical Trial of Orthokeratology Lens (MCOK-01)

Myopia

Singapore
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Dystrophic Epidermolysis Bullosa

Korea, Republic of
Anterogen Co., Ltd.

Completed

Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of

3

Subscribe